congenital athymia

An FDA mistake signals likely approval for Vivek Ramaswamy’s first therapy for children born without a thymus
Endpoints
Fri, 10/1/21 - 10:50 am
Enzyvant
Vivek Ramaswamy
FDA
congenital athymia
FDA knocks down Enzyvant candidate on manufacturing concerns after plant inspection
Fierce Biotech
Fri, 12/6/19 - 09:59 am
Enzyvant
FDA
drug manufacturing
congenital athymia
RVT-802